Viking Therapeutics Aktie
30,12
EUR
-0,26
EUR
-0,86
%
31,90
USD
-0,45
USD
-1,39
%
Werbung
Viking Therapeutics Aktie Analyse
16.07.19 | Viking Therapeutics Outperform | Oppenheimer & Co. Inc. | |
14.03.19 | Viking Therapeutics Buy | Maxim Group | |
12.12.18 | Viking Therapeutics Buy | B. Riley FBR | |
18.09.18 | Viking Therapeutics Buy | Maxim Group | |
18.09.18 | Viking Therapeutics Buy | H.C. Wainwright & Co. | |
01.06.18 | Viking Therapeutics Buy | Laidlaw | |
31.05.18 | Viking Therapeutics Buy | Maxim Group | |
26.03.18 | Viking Therapeutics Buy | H.C. Wainwright & Co. | |
Werbung
|
|||
28.11.17 | Viking Therapeutics Buy | Maxim Group | |
10.11.17 | Viking Therapeutics Buy | H.C. Wainwright & Co. | |
17.07.17 | Viking Therapeutics Buy | H.C. Wainwright & Co. | |
24.05.16 | Viking Therapeutics Buy | Maxim Group | |
07.04.16 | Viking Therapeutics Buy | H.C. Wainwright & Co. |
Werbung
Werbung